In continuation on the exploration of transparency surrounding medications, Dr. Gorfinkel investigates drug manufacturing and poses the question – where are my drugs made?
On July 10, 2018 Health Canada issued two recent drug recalls that received considerable press: one was a medication used to treat gastric hyper-acidity, ranitidine (Zantac). The other was an anti-hypertensive, valsartan (Diovan). Even after these widely publicized recalls, most patients and physicians remain completely unaware of where their drugs are manufactured. As a result, patients and physicians rarely consider issues around drug manufacturing quality when assessing medications' adverse events.
In her recent article published in the Canadian Medical Association Journal (CMAJ), Dr. Gorfinkel explores this topic and examines the current lack of transparency of where drugs are manufactured and the implications of this. Read her article, “Where are my drugs made?” by clicking the link below. CMAJ - Where are my drugs made?